A "groundbreaking" drug is being trialled in the first Brits to cure autoimmune conditions such as lupus and multiple sclerosis. Until now CAR T-cell therapy had been used only in the UK for ...

Data demonstrate potential superiority of a targeted protein degradation strategy compared to kinase inhibition for both BTK ...